Pharmacological treatment of trigeminal neuralgia

References

• Headache Classification Committee of the International Headache Society (IHS). The international classification of headache disorders, 3rd edition (beta version). Cephalalgia. 2013;33:629–808.
   PubMed Web of Science ®Google Scholar
• Katusic S, Beard CM, Bergstralh E, et al. Incidence and clinical features of trigeminal neuralgia, Rochester, Minnesota, 1945-1984. Ann Neurol. 1990;27:89–95.
   PubMed Web of Science ®Google Scholar
• Maarbjerg S, Di Stefano G, Bendtsen L, et al. Trigeminal neuralgia - diagnosis and treatment. Cephalalgia. 2017;37:648–657.
   PubMed Web of Science ®Google Scholar
• Cruccu G, Finnerup NB, Jensen TS, et al. Trigeminal neuralgia: new classification and diagnostic grading for practice and research. Neurology. 2016;87:220–228.
   PubMed Web of Science ®Google Scholar
• Sindrup SH, Jensen TS. Pharmacotherapy of trigeminal neuralgia. Clin J Pain. 2002;18:22–27.
   PubMed Web of Science ®Google Scholar
• Campbell FG, Graham JG, Zilkha KJ. Clinical trial of carbamazepine (tegretol) in trigeminal neuralgia. J Neurol Neurosurg Psychiatry. 1966;29:265–267.
   PubMed Web of Science ®Google Scholar
• Killian JM, Fromm GH. Carbamazepine in the treatment of neuralgia. Arch Neurol. 1968;19:129–136.
   PubMed Web of Science ®Google Scholar
• Nicol CF. A four year double blind study of Tegretol in facial pain. Headache. 1969;9:54–57.
   PubMedGoogle Scholar
• Rockcliff BW, Davis EH. Controlled sequential trials of carbamazepine in trigeminal neuralgia. Arch Neurol. 1996;15:129–136.
   Google Scholar
• Cruccu G, Gronseth G, Alksne J, et al.; American Academy of Neurology Society; European Federation of Neurological Society. AAN-EFNS guidelines on trigeminal neuralgia management. Eur J Neurol. 2008;15:1013–1028.
   PubMed Web of Science ®Google Scholar
• Wiffen P, Collins S, McQuay H, et al. Anticonvulsant drugs for acute and chronic pain. Cochrane Database Syst Rev. 2005; 3:CD001133.
   PubMed Web of Science ®Google Scholar
• Wiffen P, McQuay H, Moore A. Carbamazepine for acute and chronic pain. Cochrane Database Syst Rev. 2005;2:CD005451.
   PubMed Web of Science ®Google Scholar
• Liebel JT, Menger N, Langohr H. Oxcarbazepine in der Behandlung der Trigeminus neuralgie [Oxcarbazepine in the treatment of trigeminal neuralgia]. Nervenheilkunde. 2001;20:461–524.
   Google Scholar
• Beydoun A. Safety and efficacy of oxcarbazepine: results of randomized, double-blind trials. Pharmacotherapy. 2000;20:152S–158S.
   PubMed Web of Science ®Google Scholar
• Beydoun A. Clinical use of tricyclic anticonvulsants in painful neuropathies and bipolar disorders. Epilepsy Behav. 2002;3:S18–S2225.
   PubMed Web of Science ®Google Scholar
• Zakrzewska JM, Linskey ME. Trigeminal neuralgia. BMJ Clin Evid. 2014 Oct 6;2014. pii:1207 [18 p]
   PubMedGoogle Scholar
• Di Stefano G, La Cesa S, Truini A, et al. Natural history and outcome of 200 outpatients with classical trigeminal neuralgia treated with carbamazepine or oxcarbazepine in a tertiary centre for neuropathic pain. J Headache Pain. 2014;15:34.
   PubMed Web of Science ®Google Scholar
• Shaikh S, Yaacob HB, Abd Rahman RB. Lamotrigine for trigeminal neuralgia: efficacy and safety in comparison with carbamazepine. J Chin Med Assoc. 2011 Jun;74:243–249.
   PubMed Web of Science ®Google Scholar
• Zakrzewska JM, Chaudhry Z, Nurmikko TJ, et al. Lamotrigine (lamictal) in refractory trigeminal neuralgia: results from a double-blind placebo controlled crossover trial. Pain. 1997;73:223–230.
   PubMed Web of Science ®Google Scholar
• Wiffen PJ, Derry S, Moore RA. Lamotrigine for acute and chronic pain. Cochrane Database Syst Rev. 2011;16:CD006044.
   Google Scholar
• Fromm GH, Terrence CF, Chattha AS. Baclofen in the treatment of trigeminal neuralgia: double-blind study and long-term follow-up. Ann Neurol. 1984;15:240–244.
   PubMed Web of Science ®Google Scholar
• Fromm GH, Terrence CF. Comparison of L-baclofen and racemic baclofen in trigeminal neuralgia. Neurology. 1987;37:1725–1728.
   PubMed Web of Science ®Google Scholar
• Vilming ST, Lyberg T, Lataste X. Tizanidine in the management of trigeminal neuralgia. Cephalalgia. 1986;6:181–182.
   PubMed Web of Science ®Google Scholar
• Lindström P, Lindblom U. The analgesic effect of tocainide in trigeminal neuralgia. Pain. 1987;28:45–50.
   PubMed Web of Science ®Google Scholar
• Lechin F, van der Dijs B, Lechin ME, et al. Pimozide therapy for trigeminal neuralgia. Arch Neurol. 1989;46:960–963.
   PubMedGoogle Scholar
• Yang M, Zhou M, He L, et al. Non-antiepileptic drugs for trigeminal neuralgia. Cochrane Database Syst Rev. 2011;19:CD004029.
   Google Scholar
• Lemos L, Flores S, Oliveira P, et al. Gabapentin supplemented with ropivacain block of trigger points improves pain control and quality of life in trigeminal neuralgia patients when compared with gabapentin alone. Clin J Pain. 2008;24:64–75.
   PubMed Web of Science ®Google Scholar
• Obermann M, Yoon MS, Sensen K, et al. Efficacy of pregabalin in the treatment of trigeminal neuralgia. Cephalalgia. 2008;28:174–181.
   PubMed Web of Science ®Google Scholar
• Perez C, Navarro A, Saldan˜a MT, et al. Patient-reported outcomes in subjects with painful trigeminal neuralgia receiving pregabalin: evidence from medical practice in primary care settings. Cephalalgia. 2009;29:781–790.
   PubMedGoogle Scholar
• Perez C, Saldan˜a MT, Navarro A, et al. Trigeminal neuralgia treated with pregabalin in family medicine settings: its effect on pain alleviation and cost reduction. J Clin Pharmacol. 2009;49:582–590.
   PubMed Web of Science ®Google Scholar
• Rustagi A, Roychoudhury A, Bhutia O, et al. Lamotrigine versus pregabalin in the management of refractory trigeminal neuralgia: a randomized open label crossover trial. J Maxillofac Oral Surg. 2014;13:409–418.
   PubMedGoogle Scholar
• Domingues RB, Kuster GW, Aquino CC. Treatment of trigeminal neuralgia with low doses of topiramate. Arq Neuropsiquiatr. 2007;65:792–794.
   PubMed Web of Science ®Google Scholar
• Jorns TP, Johnston A, Zakrzewska JM. Pilot study to evaluate the efficacy and tolerability of levetiracetam (Keppra) in treatment of patients with trigeminal neuralgia. Eur J Neurol. 2009;16:740–744.
   PubMed Web of Science ®Google Scholar
• Mitsikostas DD, Pantes GV, Avramidis TG, et al. An observational trial to investigate the efficacy and tolerability of levetiracetam in trigeminal neuralgia. Headache. 2010;50:1371–1377.
   PubMed Web of Science ®Google Scholar
• Lemos L, Fontes R, Flores S, et al. Effectiveness of the association between carbamazepine and peripheral analgesic block with ropivacaine for the treatment of trigeminal neuralgia. J Pain Res. 2010;25(3):201–212.
   Google Scholar
• Kanai A, Suzuki A, Kobayashi M, et al. Intranasal lidocaine 8% spray for second-division trigeminal neuralgia. Br J Anaesth. 2006;97:559–563.
   PubMed Web of Science ®Google Scholar
• Niki Y, Kanai A, Hoshi K, et al. Immediate analgesic effect of 8% lidocaine applied to the oral mucosa in patients with trigeminal neuralgia. Pain Med. 2014;15:826–831.
   PubMed Web of Science ®Google Scholar
• Kondziolka D, Lemley T, Kestle JR, et al. The effect of single-application topical ophthalmic anesthesia in patients with trigeminal neuralgia. A randomized double-blind placebo-controlled trial. J Neurosurg. 1994;80:993–997.
   PubMed Web of Science ®Google Scholar
• Fusco BM, Alessandri M. Analgesic effect of capsaicin in idiopathic trigeminal neuralgia. Anesth Analg. 1992;74:375–377.
   PubMed Web of Science ®Google Scholar
• Epstein JB, Marcoe JH. Topical application of capsaicin for treatment of oral neuropathic pain and trigeminal neuralgia. Oral Surg Oral Med Oral Pathol. 1994;77:135–140.
   PubMedGoogle Scholar
• Kanai A, Saito M, Hoka S. Subcutaneous sumatriptan for refractory trigeminal neuralgia. Headache. 2006;46:577–582.
   PubMed Web of Science ®Google Scholar
• Kanai A, Suzuki A, Osawa S, et al. Sumatriptan alleviates pain in patients with trigeminal neuralgia. Clin J Pain. 2006;22:677–680.
   PubMed Web of Science ®Google Scholar
• Bohluli B, Motamedi MH, Bagheri SC, et al. Use of botulinu toxin A for drug-refractory trigeminal neuralgia: preliminary report. Oral Surg Oral Med Oral Pathol Oral Radiol Endod. 2011;111:47–50.
   PubMed Web of Science ®Google Scholar
• Wu CJ, Lian YJ, Zheng YK, et al. Botulinum toxin type A for the treatment of trigeminal neuralgia: results from a randomized, double-blind, placebo-controlled trial. Cephalalgia. 2012;32:443–450.
   PubMed Web of Science ®Google Scholar
• Zúñiga C, Dı´az S, Piedimonte F, et al. Beneficial effects of botulinum toxin type A in trigeminal neuralgia. Arq Neuropsiquiatr. 2008;66:500–503.
   PubMed Web of Science ®Google Scholar
• Piovesan EJ, Teive HG, Kowacs PA, et al. An open study of botulinum-A toxin treatment of trigeminal neuralgia. Neurology. 2005;65:1306–1308.
   PubMed Web of Science ®Google Scholar
• Türk U, Ilhan S, Alp R, et al. Botulinum toxin and intractable trigeminal neuralgia. Clin Neuropharmacol. 2005;28:161–162.
   PubMed Web of Science ®Google Scholar
• Borodic GE, Acquadro MA. The use of botulinum toxin for the treatment of chronic facial pain. J Pain. 2002;3:21–27.
   PubMed Web of Science ®Google Scholar
• Cruccu G, Truini A. Refractory trigeminal neuralgia. Non-surgical treatment options. CNS Drugs. 2013;27:91–96.
   PubMed Web of Science ®Google Scholar
• Zúñiga C, Piedimonte F, Díaz S, et al. Acute treatment of trigeminal neuralgia with onabotulinum toxin A. Clin Neuropharmacol. 2013;36:146–150.
   PubMed Web of Science ®Google Scholar
• Zhang H, Lian Y, Ma Y, et al. Two doses of botulinum toxin type A for the treatment of trigeminal neuralgia: observation of therapeutic effect from a randomized, double-blind, placebo controlled trial. J Headache Pain. 2014;15:65.
   PubMed Web of Science ®Google Scholar
• Shehata HS, El-Tamawy MS, Shalaby NM, et al. Botulinum toxintype A: could it be an effective treatment option in intractable trigeminal neuralgia? J Headache Pain. 2013;14:92.
   PubMed Web of Science ®Google Scholar
• Li S, Lian YJ, Chen Y, et al. Therapeutic effect of Botulinum toxin-A in 88 patients with trigeminal neuralgia with 14-month follow-up. J Headache Pain. 2014;15:43.
   PubMed Web of Science ®Google Scholar
• Burmeister J, Holle D, Bock E, et al. Botulinum neurotoxin type A in the treatment of classical Trigeminal Neuralgia (BoTN): study protocol for a randomized controlled trial. Trials. 2015;16:550.
   PubMed Web of Science ®Google Scholar
• Tate R, Rubin LM, Krajewski KC. Treatment of refractory trigeminal neuralgia with intravenous phenytoin. Am J Health Syst Pharm. 2011 Nov 1;68:2059–2061.
   PubMed Web of Science ®Google Scholar
• Vargas A, Thomas K. Intravenous fosphenytoin for acute exacerbation of trigeminal neuralgia: case report and literature review. Ther Adv Neurol Disord. 2015;8:187–188.
   PubMed Web of Science ®Google Scholar
• Stavropoulou E, Argyra E, Zis P, et al. The effect of intravenous lidocaine on trigeminal neuralgia: a randomized double blind placebo controlled trial. ISRN Pain. 2014;2014:853826.
   PubMedGoogle Scholar
• Arai YC, Hatakeyama N, Nishihara M, et al. Intravenous lidocaine and magnesium for management of intractable trigeminal neuralgia: a case series of nine patients. J Anesth. 2013;27:960–962.
   PubMed Web of Science ®Google Scholar
• Xu M, Chen P, Zhu X, et al. Efficacy of intravenous lidocaine and magnesium in intractable trigeminal neuralgia: a preliminary report. J Neurol Sci. 2016;371:149–151.
   PubMed Web of Science ®Google Scholar
• Chaudhry P, Friedman DI. Intravenous lidocaine treatment in classical trigeminal neuralgia with concomitant persistent facial pain. Headache. 2014;54:1376–1379.
   PubMed Web of Science ®Google Scholar
• Elsner F, Radbruch L, Gaertner J, et al. Efficacy of opioid analgesia at the superior cervical ganglion in neuropathic head and facial pain. Schmerz. 2006;20:268272,27426.
   Web of Science ®Google Scholar
• Rugiero F, Derjean D, Morisset V, et al. CNV1014802, a novel, potent Nav1.7 selective state­dependent sodium channel blocker with broad preclinical antihyperalgesic efficacy. Presented at the 14th World Congress on Pain (IASP); 2012 Aug 27-31; Milan, Italy. Abstr: PT.172.
   Google Scholar
• Zakrzewska JM, Palmer J, Morisset V, et al. Safety and efficacy of a Nav1.7 selective sodium channel blocker in patients with trigeminal neuralgia: a double-blind, placebo-controlled, randomised withdrawal phase 2a trial. Lancet Neurol. 2017;16:291–300.
   PubMed Web of Science ®Google Scholar
• Espir ML, Millac P. Treatment of paroxysmal disorders in multiple sclerosis with carbamazepine (Tegretol). J Neurol Neurosurg Psychiatry. 1970;33:528–531.
   PubMed Web of Science ®Google Scholar
• Ramsaransing G, Zwanikken C, De Keyser J. Worsening of symptoms of multiple sclerosis associated with carbamazepine. BMJ. 2000;320:1113.
   PubMed Web of Science ®Google Scholar
• Lunardi G, Leandri M, Albano C, et al. Clinical effectiveness of lamotrigine and plasma levels in essential and symptomatic trigeminal neuralgia. Neurology. 1997;48:1714–1717.
   PubMed Web of Science ®Google Scholar
• Leandri M, Lundardi G, Inglese M, et al. Lamotrigine in trigeminal neuralgia secondary to multiple sclerosis. J Neurol. 2000;247:556–558.
   PubMed Web of Science ®Google Scholar
• Khan OA. Gabapentin relieves trigeminal neuralgia in multiple sclerosis patients. Neurology. 1998;51:611–614.
   PubMed Web of Science ®Google Scholar
• Solaro C, Lunardi GL, Capello E, et al. An open-label trial of gabapentin treatment of paroxysmal symptoms in multiple sclerosis patients. Neurology. 1998;51:609–611.
   PubMed Web of Science ®Google Scholar
• Solaro C, Boehmker M, Tanganelli P. Pregabalin for treating paroxysmal painful symptoms in multiple sclerosis: a pilot study. J Neurol. 2009;256:1773–1774.
   PubMed Web of Science ®Google Scholar
• Zvartau‑Hind M, Din MU, Gilani A, et al. Topiramate relieves refractory trigeminal neuralgia in MS patients. Neurology. 2000;55:1587–1588.
   PubMed Web of Science ®Google Scholar
• Solaro C, Uccelli MM, Brichetto G, et al. Topiramate relieves idiopathic and symptomatic trigeminal neuralgia. J Pain Symptom Manage. 2001;21:367–368.
   PubMed Web of Science ®Google Scholar
• D’Aleo G, Sessa E, Di Bella P, et al. Topiramate modulation of R3 nociceptive reflex in multiple sclerosis patients suffering paroxysmal symptoms. J Neurol. 2001;248:996–999.
   PubMed Web of Science ®Google Scholar
• Reder AT, Arnason BG. Trigeminal neuralgia in multiple sclerosis relieved by a prostaglandin E analogue. Neurology. 1995;45:1097–1100.
   PubMed Web of Science ®Google Scholar
• DMKG study group. Misoprostol in the treatment of trigeminal neuralgia associated with multiple sclerosis. J Neurol. 2003;250:542–545.
   PubMed Web of Science ®Google Scholar
• Pfau G, Brinkers M, Treuheit T, et al. Misoprostol as a therapeutic option for trigeminal neuralgia in patients with multiple sclerosis. Pain Med. 2012;13:1377–1378.
   PubMed Web of Science ®Google Scholar
• Solaro C, Messmer Uccelli M, Uccelli A, et al. Low-dose gabapentin combined with either lamotrigine or carbamazepine can be useful therapies for trigeminal neuralgia in multiple sclerosis. Eur Neurol. 2000;44:45–48.
   PubMed Web of Science ®Google Scholar
• Burchiel KJ. Abnormal impulse generation in focally demyelinated trigeminal roots. J Neurosurg. 1980;53:674–683.
   PubMed Web of Science ®Google Scholar
• Calvin WH, Devor M, Howe JF. Can neuralgias arise from minor demyelination? Spontaneous firing, mechanosensitivity, and afterdischarge from conducting axons. Exp Neurol. 1982;75:755–763.
   PubMed Web of Science ®Google Scholar
• Devor M, Amir R, Rappaport ZH. Pathophysiology of trigeminal neuralgia: the ignition hypothesis. Clin J Pain. 2002;18:4–13.
   PubMed Web of Science ®Google Scholar
• Attal N, Cruccu G, Baron R, et al. EFNS guidelines on the pharmacological treatment of neuropathic pain: 2010 revision. Eur J Neurol. 2010;17:1113–1123.
   PubMed Web of Science ®Google Scholar
• Besi E, Boniface DR, Cregg R, et al. Comparison of tolerability and adverse symptoms in oxcarbazepine and carbamazepine in the treatment of trigeminal neuralgia and neuralgiform headaches using the Liverpool Adverse Events Profile (AEP). J Headache Pain. 2015;16:563.
   PubMed Web of Science ®Google Scholar
• Obermann M. Treatment options in trigeminal neuralgia. Ther Adv Neurol Disord. 2010;3:107–115.
   PubMedGoogle Scholar
• Gomez-Arguelles JM, Dorado R, Sepulveda JM, et al. Oxcarbazepine monotherapy in carbamazepine-unresponsive trigeminal neuralgia. J Clin Neurosci. 2008;15:516–519.
   PubMed Web of Science ®Google Scholar
• Wiffen PJ, Rees J. Lamotrigine for acute and chronic pain. Cochrane Database Syst Rev. 2007;18:CD006044.
   Google Scholar
• Aoki KR. Review of a proposed mechanism for the antinociceptive action of botulinum toxin type A. Neurotoxicology. 2005;26:785793.
   Web of Science ®Google Scholar
• Cheshire WP. Fosphenytoin: an intravenous option for the management of acute trigeminal neuralgia crisis. J Pain Symptom Manage. 2001;21:506–510.
   PubMed Web of Science ®Google Scholar
• Pöllmann W, Feneberg W. Current management of pain associated with multiple sclerosis. CNS Drugs. 2008;22:291–324.
   PubMed Web of Science ®Google Scholar
• Solaro C, Uccelli MM. Management of pain in multiple sclerosis: a pharmacological approach. Nat Rev Neurol. 2011;16(7):519–527.
   Web of Science ®Google Scholar